References

• Hoffmann, J. P., Liu, J. A., Seddu, K., & Klein, S. L. (2023). Sex hormone signaling and regulation of immune function. Immunity, 56(11), 2472–2491. https://doi.org/10.1016/j.immuni.2023.10.008
• Kim, Y. J., Soto, M., Branigan, G. L., Rodgers, K., & Brinton, R. D. (2021). Association between menopausal hormone therapy and risk of neurodegenerative diseases: Implications for precision hormone therapy. Alzheimer’s & Dementia: Translational Research & Clinical Interventions, 7(1), Article e12174. https://doi.org/10.1002/trc2.12174
• Livingston, G., Huntley, J., Liu, K. Y., Costafreda, S. G., Selbæk, G., Alladi, S., Ames, D., Banerjee, S., Burns, A., Brayne, C., Fox, N. C., Ferri, C. P., Gitlin, L. N., Howard, R., Kales, H. C., Kivimäki, M., Larson, E. B., Nakasujja, N., Rockwood, K., … Mukadam, N. (2024). Dementia prevention, intervention, and care: 2024 report of the Lancet Standing Commission. The Lancet, 404(10452), 572–628. https://doi.org/10.1016/S0140-6736(24)01296-0
• Matthews, K. A., Kuller, L. H., Sutton-Tyrrell, K., & Chang, Y.-F. (2001). Changes in cardiovascular risk factors during the perimenopause and postmenopause and carotid artery atherosclerosis in healthy women. Stroke, 32(5), 1104–1111. https://doi.org/10.1161/01.STR.32.5.1104
• McCarthy, M., & Raval, A. P. (2020). The perimenopause in a woman’s life: A systemic inflammatory phase that enables later neurodegenerative disease. Journal of Neuroinflammation, 17(1), Article 317. https://doi.org/10.1186/s12974-020-01998-9
• Mosconi, L. (2024). The menopause brain: New science empowers women to navigate menopause with knowledge and confidence. Avery.
• Mosconi, L., Nerattini, M., Matthews, D. C., Jett, S., Andy, C., Williams, S., Yepez, C. B., Zarate, C., Carlton, C., Fauci, F., Ajila, T., Pahlajani, S., Andrews, R., Pupi, A., Ballon, D., Kelly, J., Osborne, J. R., Nehmeh, S., Fink, M., … Brinton, R. D. (2024). In vivo brain estrogen receptor density by neuroendocrine aging and relationships with cognition and symptomatology. Scientific Reports, 14(1), Article 12680. https://doi.org/10.1038/s41598-024-62820-7
• Paschou, S. A., Athanasiadou, K. I., & Papanas, N. (2024). Menopausal hormone therapy in women with type 2 diabetes mellitus: An updated review. Diabetes Therapy, 15(4), 741–748. https://doi.org/10.1007/s13300-024-01546-1
• Pe’er, E. (2021). Progestogens and the menopause. In H. J. A. Carp (Ed.), Progestogens in obstetrics and gynecology (pp. 193–202). Springer. https://doi.org/10.1007/978-3-030-52508-8_12
• Cerdas Pérez, S. (2023). Menopause and diabetes. Climacteric, 26(3), 216–221. https://doi.org/10.1080/13697137.2023.2184252
• Bollam, R., Karam, J., Shufelt, C., & Faubion, S. S. (2026). Menopausal hormone therapy and breast cancer: Balancing risks and benefits. Maturitas, 208, 108894. https://doi.org/10.1016/j.maturitas.2026.108894
• Echeverria, V., Echeverria, F., Barreto, G. E., Echeverría, J., & Mendoza, C. (2021). Estrogenic plants: To prevent neurodegeneration and memory loss and other symptoms in women after menopause. Frontiers in Pharmacology, 12, Article 644103. https://doi.org/10.3389/fphar.2021.644103
• García-Nicolás, M., Jarrín-Orozco, M. P., Romo-Vaquero, M. R., Martínez-Nortes, M. E., Ávila-Gálvez, M. Á., & Espín, J. C. (2026). Dietary (poly)phenols, the gut-brain axis, and menopause: A perspective on an overlooked biological crossroad. Food & Function. Advance online publication. https://doi.org/10.1039/D6FO00429F
• Georgakis, M. K., Beskou-Kontou, T., Theodoridis, I., Skalkidou, A., & Petridou, E. Th. (2019). Surgical menopause in association with cognitive function and risk of dementia: A systematic review and meta-analysis. Psychoneuroendocrinology, 106, 9–19. https://doi.org/10.1016/j.psyneuen.2019.03.013
• Goel, M., Ly, K., & Wolfman, W. (2024, September 10–14). Retrospective analysis of the use of menopausal hormone therapy in women more than 65 years of age: First Canadian experience [Conference presentation]. 2024 Annual Meeting of The Menopause Society, Chicago, IL, United States.
• Harder, J. A., Fichorova, R. N., Srivastava, A., Wiley, A., Burdick, K. E., Locascio, J. J., & Joffe, H. (2022). Brain-derived neurotrophic factor and mood in perimenopausal depression. Journal of Affective Disorders, 300, 145–149. https://doi.org/10.1016/j.jad.2021.12.092
• Lephart, E. D., Weber, K. S., & Hedges, D. W. (2026). Assessing the roles of aging, estrogen, nutrition, and neuroinflammation in women and their involvement in Alzheimer's disease: A narrative overview. International Journal of Molecular Sciences, 27(3), Article 1239. https://doi.org/10.3390/ijms27031239
• Mondal, S., Mandal, S., Bhat, S., Aalpona, F. T. Z., & Kamrul-Hasan, A. B. M. (2026). Role of hormone replacement therapy in managing menopausal mental health. Bangladesh Journal of Endocrinology and Metabolism, 5(1), 33–42. DOI: 10.4103/bjem.bjem_36_25
• Prossnitz, E. R., & Barton, M. (2023). The G protein-coupled oestrogen receptor GPER in health and disease: An update. Nature Reviews Endocrinology, 19(7), 407–424. https://doi.org/10.1038/s41574-023-00822-7
• Shieu, M. M., Braley, T. J., Becker, J., & Dunietz, G. L. (2023). The interplay among natural menopause, insomnia, and cognitive health: A population-based study. Nature and Science of Sleep, 15, 39–48. https://doi.org/10.2147/NSS.S398019
• Singh, M., Krishnamoorthy, V. R., Kim, S., Khurana, S., & LaPorte, H. M. (2024). Brain-derived neurotrophic factor and related mechanisms that mediate and influence progesterone-induced neuroprotection. Frontiers in Endocrinology, 15, Article 1286066. https://doi.org/10.3389/fendo.2024.1286066
• Turek, J., & Gąsior, Ł. (2023). Estrogen fluctuations during the menopausal transition are a risk factor for depressive disorders. Pharmacological Reports, 75(1), 32–43. https://doi.org/10.1007/s43440-022-00444-2
• Williams, V. J., Koscik, R., Sicinski, K., Johnson, S. C., Herd, P., & Asthana, S. (2023). Associations between midlife menopausal hormone therapy use, incident diabetes, and late life memory in the Wisconsin Longitudinal Study. Journal of Alzheimer's Disease, 93(2), 727–741. https://doi.org/10.3233/JAD-221240